Premenstrual dysphoric disorder
Cluster Number:
Wiki Number: PW175
Diagnosis: Premenstrual Dypshoric Disorder
US Patients:
World Patients: 1.8-5.8% of menstruating women.
Sex Ratio:
Age Onset:
Brain Area: serotonin receptors in the hippocampus and prefrontal cortex are affected by estrogen and progesterone activities
Symptoms: pain and mood changes for up to two weeks before menstruation.
Progression:
Causes: genetic and fluctuating hormones during the menstrual cycle;
Medications: antidepressants, SSRIs, ovulation suppression with birth-control pills and GnRH analogues. SSRIs are most common & help 50%.
Therapies: CBT
Youtube Video:
What It’s Like To Have Premenstrual Dysphoric Disorder
Amazon or Library Book: The PMDD Phenomenon
Click the book to link or order from Amazon.
Support Group” viciouscyclepmdd.com-iampt.org
(International Association for Premenstrual Disorder)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Impact of premenstrual syndrome and premenstrual dysphoric disorder on maternal antenatal depressionby Nozomi Ihara on December 19, 2024
In this study, we aimed to determine the association of premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) with maternal antenatal depression. This cross-sectional, online questionnaire-based observational study included 212 pregnant women between gestational ages 24 weeks and 28 weeks 6 days. PMS and PMDD were measured using the PMDD Scale, and maternal antenatal depression was evaluated using the Edinburgh Postnatal Depression Scale. Baseline characteristics, clinical...
- Disseminating Premenstrual Dysphoric Disorder Information on TikTok: A Content Analysisby Lili R Romann on December 17, 2024
Premenstrual dysphoric disorder (PMDD) is characterized as an extreme form of premenstrual syndrome (PMS) in which a combination of severe mood, somatic, and cognitive symptoms present one to two weeks prior to the onset of menstruation. As people increasingly turn to social media, specifically TikTok, to gain information about health-related topics and information, discourse about this taboo chronic condition has increased. Sensitized by concepts from the theory of communicative...
- Development and validation of the premenstrual dysphoric disorder scale in Indian femalesby Asmita Jain on December 13, 2024
CONCLUSION: The scale developed in this study was found reliable and valid for use on the Indian population. It has high sensitivity and can be used as a screening measure for premenstrual dysphoric disorder.
- PvuII-ESR1 gene polymorphism in premenstrual dysphoric disorder in South Indian womenby Shuchi Odiyanda Charmanna on December 13, 2024
CONCLUSION: PvuII-ESR1 SNP (T/C rs2234693) does not show any association with phenotype between the control and PMDD. However, PMDDAS questionnaire can be used to differentiate the women who are controls from PMDD.